Viemed Net Income vs Cost Of Revenue Analysis

VMD Stock

USD 7.11 0.04 0.57%

Viemed Healthcare financial indicator trend analysis is much more than just breaking down Viemed Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Viemed Healthcare is a good investment. Please check the relationship between Viemed Healthcare Net Income and its Cost Of Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.

Net Income vs Cost Of Revenue

Net Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Viemed Healthcare Net Income account and Cost Of Revenue. At this time, the significance of the direction appears to have weak relationship.

The correlation between Viemed Healthcare's Net Income and Cost Of Revenue is 0.3. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Viemed Healthcare, assuming nothing else is changed. The correlation between historical values of Viemed Healthcare's Net Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Viemed Healthcare are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Net Income i.e., Viemed Healthcare's Net Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.3

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Viemed Healthcare financial statement analysis. It represents the amount of money remaining after all of Viemed Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Cost Of Revenue

Cost of Revenue is found on Viemed Healthcare income statement and represents the costs associated with goods and services Viemed Healthcare provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Viemed Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Viemed Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.The current year's Tax Provision is expected to grow to about 3.9 M, whereas Selling General Administrative is forecasted to decline to about 50.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	73.4M	84.7M	113.4M	66.0M
Total Revenue	117.1M	138.8M	186.4M	102.0M

Gross Profit Total Revenue

Viemed Healthcare fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Inventory	Total Liab	Short Long Term Debt	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.87	0.91	0.99	0.94	0.99	0.58	0.82	0.87	0.95	0.82	0.86	0.17	0.94	0.89	0.99	0.24	0.99	0.54	-0.67	0.98	0.65	0.95
Other Current Liab	0.87		0.87	0.84	0.94	0.84	0.6	0.67	0.88	0.83	0.79	0.82	0.13	0.8	0.91	0.84	0.29	0.88	0.4	-0.46	0.88	0.38	0.85
Total Current Liabilities	0.91	0.87		0.85	0.81	0.84	0.74	0.67	0.88	0.85	0.73	0.98	0.1	0.8	0.74	0.92	0.51	0.92	0.45	-0.39	0.84	0.34	0.78
Total Stockholder Equity	0.99	0.84	0.85		0.94	1.0	0.52	0.82	0.82	0.95	0.84	0.77	0.14	0.95	0.91	0.97	0.11	0.97	0.54	-0.74	0.99	0.71	0.97
Net Tangible Assets	0.94	0.94	0.81	0.94		0.94	0.52	0.78	0.87	0.9	0.8	0.74	0.13	0.9	0.98	0.9	0.13	0.94	0.53	-0.65	0.96	0.61	0.95
Retained Earnings	0.99	0.84	0.84	1.0	0.94		0.52	0.86	0.81	0.94	0.82	0.77	0.15	0.97	0.9	0.96	0.12	0.97	0.51	-0.78	0.99	0.75	0.96
Accounts Payable	0.58	0.6	0.74	0.52	0.52	0.52		0.43	0.48	0.5	0.54	0.67	-0.45	0.5	0.4	0.64	0.25	0.62	0.02	-0.25	0.46	0.13	0.39
Cash	0.82	0.67	0.67	0.82	0.78	0.86	0.43		0.71	0.69	0.47	0.65	0.26	0.96	0.69	0.8	0.23	0.8	0.21	-0.88	0.81	0.88	0.73
Long Term Debt	0.87	0.88	0.88	0.82	0.87	0.81	0.48	0.71		0.83	0.57	0.89	0.39	0.81	0.84	0.88	0.53	0.91	0.51	-0.4	0.86	0.43	0.82
Net Receivables	0.95	0.83	0.85	0.95	0.9	0.94	0.5	0.69	0.83		0.82	0.78	0.2	0.87	0.89	0.93	0.17	0.94	0.64	-0.58	0.95	0.56	0.95
Inventory	0.82	0.79	0.73	0.84	0.8	0.82	0.54	0.47	0.57	0.82		0.59	-0.15	0.67	0.79	0.79	-0.16	0.78	0.43	-0.51	0.82	0.39	0.84
Total Liab	0.86	0.82	0.98	0.77	0.74	0.77	0.67	0.65	0.89	0.78	0.59		0.24	0.75	0.67	0.87	0.67	0.87	0.42	-0.3	0.78	0.29	0.71
Short Long Term Debt	0.17	0.13	0.1	0.14	0.13	0.15	-0.45	0.26	0.39	0.2	-0.15	0.24		0.23	0.17	0.14	0.49	0.18	0.13	-0.07	0.23	0.23	0.21
Total Current Assets	0.94	0.8	0.8	0.95	0.9	0.97	0.5	0.96	0.81	0.87	0.67	0.75	0.23		0.83	0.92	0.19	0.93	0.38	-0.84	0.94	0.83	0.88
Common Stock	0.89	0.91	0.74	0.91	0.98	0.9	0.4	0.69	0.84	0.89	0.79	0.67	0.17	0.83		0.85	0.09	0.89	0.6	-0.58	0.94	0.55	0.96
Property Plant Equipment	0.99	0.84	0.92	0.97	0.9	0.96	0.64	0.8	0.88	0.93	0.79	0.87	0.14	0.92	0.85		0.27	0.99	0.5	-0.64	0.95	0.62	0.92
Short Long Term Debt Total	0.24	0.29	0.51	0.11	0.13	0.12	0.25	0.23	0.53	0.17	-0.16	0.67	0.49	0.19	0.09	0.27		0.28	0.14	0.25	0.17	-0.16	0.07
Property Plant And Equipment Net	0.99	0.88	0.92	0.97	0.94	0.97	0.62	0.8	0.91	0.94	0.78	0.87	0.18	0.93	0.89	0.99	0.28		0.51	-0.63	0.97	0.61	0.93
Current Deferred Revenue	0.54	0.4	0.45	0.54	0.53	0.51	0.02	0.21	0.51	0.64	0.43	0.42	0.13	0.38	0.6	0.5	0.14	0.51		-0.11	0.56	0.18	0.63
Net Debt	-0.67	-0.46	-0.39	-0.74	-0.65	-0.78	-0.25	-0.88	-0.4	-0.58	-0.51	-0.3	-0.07	-0.84	-0.58	-0.64	0.25	-0.63	-0.11		-0.7	-0.97	-0.65
Net Invested Capital	0.98	0.88	0.84	0.99	0.96	0.99	0.46	0.81	0.86	0.95	0.82	0.78	0.23	0.94	0.94	0.95	0.17	0.97	0.56	-0.7		0.68	0.99
Net Working Capital	0.65	0.38	0.34	0.71	0.61	0.75	0.13	0.88	0.43	0.56	0.39	0.29	0.23	0.83	0.55	0.62	-0.16	0.61	0.18	-0.97	0.68		0.65
Capital Stock	0.95	0.85	0.78	0.97	0.95	0.96	0.39	0.73	0.82	0.95	0.84	0.71	0.21	0.88	0.96	0.92	0.07	0.93	0.63	-0.65	0.99	0.65

Click cells to compare fundamentals

Viemed Healthcare Account Relationship Matchups

Viemed Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	82.6M	112.6M	118.0M	117.0M	154.1M	88.3M
Other Current Liab	9.1M	12.9M	8.9M	11.1M	19.6M	20.6M
Total Current Liabilities	25.9M	23.0M	17.8M	18.9M	32.0M	20.2M
Total Stockholder Equity	43.7M	81.7M	94.8M	97.1M	113.3M	62.8M
Other Liab	2.3M	859K	757K	889K	1.0M	816.6K
Net Tangible Assets	43.7M	81.7M	94.8M	97.1M	111.7M	117.2M
Retained Earnings	34.1M	65.6M	73.3M	69.8M	79.1M	48.5M
Accounts Payable	4.7M	2.1M	3.2M	2.7M	4.2M	3.5M
Cash	13.4M	31.0M	28.4M	16.9M	12.8M	15.3M
Non Current Assets Total	54.8M	65.4M	70.7M	77.3M	115.9M	121.7M
Non Currrent Assets Other	13K	863K	862K	1.6M	727.3K	690.9K
Other Assets	13K	9.6M	5.6M	4.7M	1.0	0.95
Long Term Debt	7.6M	5.8M	4.3M	6.0M	6.9M	7.2M
Cash And Short Term Investments	13.4M	31.0M	28.4M	16.9M	12.8M	14.9M
Net Receivables	11.5M	12.4M	14.7M	15.4M	18.4M	12.7M
Common Stock Total Equity	3.4M	9.2M	14.0M	15.1M	17.4M	18.3M
Common Stock Shares Outstanding	39.7M	40.5M	40.7M	39.8M	40.4M	38.7M
Long Term Debt Total	394K	10.7M	5.8M	4.3M	5.0M	3.9M
Liabilities And Stockholders Equity	82.6M	112.6M	118.0M	117.0M	154.1M	85.6M
Non Current Liabilities Total	13.0M	7.9M	5.3M	1.1M	8.8M	5.0M
Capital Surpluse	6.4M	7.3M	7.7M	12.1M	13.9M	14.6M
Capital Lease Obligations	10.1M	3.5M	732K	694K	3.3M	2.9M
Inventory	1.4M	2.3M	2.5M	3.6M	4.6M	2.7M
Other Current Assets	1.6M	1.5M	1.7M	3.8M	2.4M	1.6M
Other Stockholder Equity	6.4M	7.3M	7.7M	12.1M	15.6M	9.2M
Total Liab	38.9M	30.9M	23.1M	19.9M	40.8M	25.5M
Property Plant And Equipment Gross	54.8M	55.1M	90.9M	108.3M	129.8M	136.3M
Short Long Term Debt	1.8M	1.8M	1.5M	1.1M	1.2M	1.1M
Total Current Assets	27.8M	47.2M	47.3M	39.7M	38.2M	32.3M
Accumulated Other Comprehensive Income	(8.8M)	(157K)	(451K)	(278K)	(319.7K)	(335.7K)
Short Term Debt	8.8M	4.6M	1.9M	495K	2.0M	2.6M
Common Stock	3.4M	9.2M	14.0M	15.1M	18.6M	19.5M
Property Plant Equipment	54.8M	55.1M	62.8M	68.4M	78.7M	43.3M
Short Long Term Debt Total	19.5M	11.1M	6.5M	694K	10.3M	8.7M
Property Plant And Equipment Net	54.8M	55.1M	62.8M	68.4M	76.5M	52.6M
Current Deferred Revenue	3.3M	3.4M	3.8M	4.6M	6.2M	4.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
C	Citigroup
GOOG	Alphabet Inc Class C

When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:

How To Invest In Viemed

Details

Is Viemed Stock a good investment?

Details

What is Viemed Healthcare's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Viemed Stock analysis

When running Viemed Healthcare's price analysis, check to measure Viemed Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viemed Healthcare is operating at the current time. Most of Viemed Healthcare's value examination focuses on studying past and present price action to predict the probability of Viemed Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viemed Healthcare's price. Additionally, you may evaluate how the addition of Viemed Healthcare to your portfolios can decrease your overall portfolio volatility.

	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules

Is Viemed Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.006

Earnings Share

0.25

Revenue Per Share

5.041

Quarterly Revenue Growth

0.279

Return On Assets

0.0716

The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Viemed Net Income vs Cost Of Revenue Analysis

Net Income vs Cost Of Revenue

Net Income vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Net Income

Cost Of Revenue

Viemed Healthcare fundamental ratios Correlations

Viemed Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Viemed Healthcare fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Viemed Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets
Property Plant Equipment	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Assets
Net Invested Capital	+ 0.99	Total Stockholder Equity

Net Working Capital	- 0.97	Net Debt
Net Debt	- 0.88	Cash
Net Debt	- 0.84	Total Current Assets
Net Debt	- 0.78	Retained Earnings
Net Debt	- 0.74	Total Stockholder Equity
Net Invested Capital	- 0.7	Net Debt